
Intuitive Surgical, Inc. (ISRG)
- Previous close
438.00 - Open
402.49 - Bid 425.09 x 100
- Ask 408.00 x 100
- Day's range
398.99 - 432.49 - 52-week range
328.57 - 603.88 - Volume
1,918,302 - Avg. Volume
2,549,356 - Market cap (intra-day)
150.083B - Beta (5Y monthly) --
- PE ratio (TTM)
48.72 - EPS (TTM)
8.72 - Earnings date 20 Oct 2026
- Forward dividend & yield -- (0.00%)
- Ex-dividend date --
- 1y target est
478.87
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
www.intuitive.com17,021
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Medical Instruments & Supplies
Industry
Recent news
View morePerformance overview
Trailing total returns as of 21/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD return
1-year return
3-year return
5-year return
Earnings trends
View moreAnalyst insights
View moreStatistics
View moreValuation measures
Market cap
142.05B
Enterprise value
136.83B
Trailing P/E
46.11
Forward P/E
33.33
PEG ratio (5-yr expected)
1.87
Price/sales (ttm)
13.11
Price/book (mrq)
7.82
Enterprise value/revenue
12.40
Enterprise value/EBITDA
32.23
Financial highlights
Profitability and income statement
Profit margin
25.54%
Return on assets (ttm)
10.61%
Return on equity (ttm)
17.93%
Revenue (ttm)
11.58B
Net income avi to common (ttm)
2.96B
Diluted EPS (ttm)
8.72
Balance sheet and cash flow
Total cash (mrq)
6.8B
Total debt/equity (mrq)
--
Levered free cash flow (ttm)
--
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.








